Abstract | The fate of developing T cells is specified by the interaction of their antigen receptors with self-peptide-MHC complexes that are displayed by thymic antigen-presenting cells (APCs). Various subsets of thymic APCs are strategically positioned in particular thymic microenvironments and they coordinate the selection of a functional and self-tolerant T cell repertoire. In this Review, we discuss the different strategies that these APCs use to sample and process self antigens and to thereby generate partly unique, 'idiosyncratic' peptide-MHC ligandomes. We discuss how the particular composition of the peptide-MHC ligandomes that are presented by specific APC subsets not only shapes the T cell repertoire in the thymus but may also indelibly imprint the behaviour of mature T cells in the periphery. 
The recognition of self peptides that are embedded in MHC molecules on thymic antigen-presenting cells (APCs) is crucial for determining the fate of developing αβ T cells. Somewhat paradoxically, recognition of self can elicit diametrically opposed outcomes. On one hand, it is essential for thymocyte survival and commitment to either the CD4 + or CD8 + T cell lineage (that is, for the positive selection of thymocytes). On the other hand, recognition of self can be a death verdict for thymocytes, mediating the negative selection (also known as clonal deletion) of these cells, or it can skew cells to alternative fates, such as regulatory T (T Reg ) cell differentiation. The classical affinity model of thymocyte selection offers an attractive conceptual framework to resolve this apparent contradiction
. However, it does not take into account the fact that positive selection and negative selection mainly occur in discrete thymic micro environments -namely, the cortex and the medulla, respectively. Both compartments contain selection niches that are composed of different types of APCs (FIG. 1) , thereby providing microenvironments that coordinate a spatial and temporal segregation of thymocyte selection. In this Review, we focus on recent advances in our understanding of the key features of individual thymic APC subsets and discuss how these relate to the generation of a functional and self-tolerant αβ T cell repertoire.
Antigen presentation in the cortex
At the peak of its productivity, the mouse thymus generates around 50 million CD4 + CD8
+ double-positive (DP) thymocytes each day that audition for selection 1 . More than 90% of these precursors are subject to death by neglect, as they express 'useless' T cell receptors (TCRs) that do not mediate positive selection. Positive selection of 'mainstream' αβ T cells is contingent on permissive interactions with a single APC type -namely, the cortical thymic epithelial cells (cTECs). For conceptual clarity, we therefore restrict a more detailed discussion of antigen presentation in the cortex to cTECs and their role in positive selection, and only briefly discuss negative selection in the cortex.
Cortical thymic epithelial cells cTECs are arranged in a three-dimensional scaffold that supports intimate interactions with doublenegative (DN) and DP thymocytes. In addition, individual cTECs can form multicellular complexes that encompass up to 20 thymocytes, and these cTECs are referred to as thymic nurse cells (TNCs). TNC numbers are decreased in TCR-transgenic mice, possibly as a consequence of the 'facilitated' transit of thymocytes through β-selection and positive selection 2 . Thus, it seems that TNC formation is not essential for T cell development per se, but that it may result from lengthy 'audition' events that occur when only a small subset Negative selection (Also known as clonal deletion). The intrathymic elimination of double-positive or singlepositive thymocytes that express T cell receptors with high affinity for self antigens.
Death by neglect
A form of programmed cell death that occurs when double-positive thymocytes fail to engage in positively selecting interactions with self-peptide-MHC complexes on cortical thymic epithelial cells within their finite lifespan of 3-4 days.
β-selection
The pre-T cell receptor (pre-TCR)-driven process by which double-negative thymocytes that carry a productively rearranged TCR β-chain undergo proliferative expansion and developmental progression.
Peptide-MHC ligandome
(pMHC ligandome). The repertoire of peptides that are bound by MHC molecules.
Proteasome
The standard proteasome is composed of 14 α-subunits and 14 β-subunits. Three of the β-subunits (β1, β2 and β5) are involved in peptide-bond cleavage. Interferon-γ induces the expression of the immunosubunits β1i, β2i and β5i that can replace the catalytic subunits of the standard proteasome to generate the immunoproteasome, which has distinct cleavage-site preferences.
Macroautophagy
The generally nonspecific sequestration of cytoplasm into a double-or multiplemembrane-delimited compartment (autophagosome) of non-lysosomal origin. Certain proteins, organelles and pathogens may be selectively degraded by this process.
of DP thymocytes meets the positive selection criteria. Consistent with this, in non-TCR-transgenic mice TNCs were enriched with thymocytes that had secondary TCRα rearrangements 2 . Whether such unusual selection niches are indeed required to promote thymo cyte survival and/or continued TCR rearrangements remains to be shown.
Why is positive selection crucially dependent on a single stromal cell type, when tolerance (as discussed further below) can be mediated by a variety of cell types? One might assume that the essential function of cTECs simply depends on their location and abundant surface expression of MHC molecules. However, this is not the case. Instead, it is becoming increasingly clear that the crucial role of cTECs is, at least in part, a result of the unique machineries that these cells use to process antigens. It is likely that these proteolytic pathways (FIG. 2) -which are reviewed in REF. 3 -endow cTECs with a largely unique peptide-MHC ligandome (pMHC ligandome) that is distinct from that displayed by any other thymic or peripheral APC.
Antigen processing in cTECs. In terms of MHC class I antigen presentation, cTECs express a unique catalytic subunit of the proteasome that is referred to as β5t (also known as PSMB11). Proteasomes that incorporate β5t are referred to as 'thymoproteasomes' . They have a substrate preference that is distinct from proteasomes containing the β5 (also known as PSMB5) or β5i (also known as PSMB8) subunits 4 , which are termed 'housekeeping proteasomes' and 'immunoproteasomes' , respectively. Mice that lack thymoproteasomes show a substantial defect in the positive selection of CD8 + T cells 5 .
In terms of MHC class II antigen presentation, cTECs express the unique lysosomal proteases cathepsin L (also known as cathepsin L1) and thymus-specific serine protease (TSSP). Deficiency of these proteases results in the impaired selection of CD4 + T cells 6, 7 . Cathepsin L-deficient mice show a strongly decreased polyclonal CD4 + T cell repertoire in the thymus 6 , whereas TSSPdeficient mice have normal polyclonal CD4 + T cell numbers but display defective positive selection of certain MHC class II-restricted transgenic TCRs, as well as altered antigen-specific CD4 + T cell responses 7 . Moreover, cTECs display an unusually high rate of constitutive macroautophagy, a mechanism that can support the 'unconventional' loading of peptides onto MHC class II molecules via an endogenous route 8 . Positive selection of several MHC class II-restricted transgenic TCRs was altered upon interference with macroautophagy in the thymic epithelium, which is consistent with the idea that autophagy shapes the MHC class II ligandome of cTECs 9 . Bearing in mind that the affinity model of thymocyte selection does not envisage any need for unique positively selecting peptides, why may these distinct processing pathways have evolved? Do they generate 'private' peptides that are exclusively displayed by cTECs and that have unique properties that are required for positive selection? Or do these peptides simply dilute ubiquitous 'public' peptides, which are nonetheless the major mediators of positive selection? Alternatively, do peptides on cTECs merely have to be different from those presented by other thymic APCs? The latter proposition is supported by the finding that the reconstitution of cathepsin L-deficient mice with MHC class II-deficient bone marrow -which abrogates the negative selection of CD4 + T cells by haematopoietic APCs -mostly
Box 1 | The affinity model of thymocyte selection
The affinity model of thymocyte selection (see figure) centres on the strength of the interaction of the T cell receptor (TCR) with self-peptide-MHC complexes as a crucial determinant of cell fate. Weak interactions are required to protect thymocytes from death by neglect and to promote the positive selection of naive T cells. Strong interactions cause negative selection by apoptosis. Studies in TCR-transgenic mice have shown that negatively selecting peptides are primarily high-affinity agonists (including cognate ligands; that is, peptides that lead to the activation of mature T cells), whereas positively selecting peptides are often low-affinity antagonists or weak agonists (often called altered peptide ligands). Interestingly, in TCR-transgenic systems, high-affinity agonists were also shown to cause clonal deviation -that is, the redirection of autoreactive T cells into the regulatory T (T Reg ) cell lineage. A surprisingly broad range of affinities seems to be permissive for T Reg cell differentiation, and as the affinity of the TCR-MHC interaction increases, the propensity to generate T Reg cells increases. Thus, a modified version of the affinity model, where T Reg cell differentiation occurs optimally within a window between positive selection and negative selection, is currently favoured. Of note, the demarcation between clonal deletion and clonal deviation is remarkably plastic and seems to be subject to stochastic influences. rescued their CD4 + T cell compartment 10 . This indicates that the positive selection of CD4 + T cells by cathepsin Ldeficient cTECs is not inefficient per se; however, an unusually large fraction of cells that are selected in this way are subject to negative selection. Hence, positive selection on different (but not functionally unique) ligands might be necessary to prevent a disproportionate loss of T cells owing to subsequent re-encounter of the very same peptides that mediated positive selection in a 'negatively selecting setting' -namely, on medullary APCs that express abundant co-stimulatory molecules 3 . Nevertheless, several observations concerning the role of the thymoproteasome in the selection of CD8 + T cells suggest a different scenario. Neither the reconstitution with MHC class I-deficient bone marrow cells nor the inactivation of the gene that encodes BCL-2-interacting mediator of cell death (BIM; also known as BCL2L11) rescued the CD8 + T cell compartment of thymo proteasome-deficient mice 11, 12 . Therefore, the role of thymoproteasome-dependent peptides cannot be to avoid excessive thymocyte deletion. Gene-replacement experiments provide further evidence for the notion that it is the actual nature of the peptides that are generated by the thymoproteasome -rather than a mere difference between the pMHC repertoires of cTECs and other APCs -that matters. By inserting the gene that encodes β5i into the locus of the gene that encodes β5t in β5i-deficient mice, animals were engineered in which, independently of β5t, the MHC class I ligandomes differed between cTECs and other APCs (in this case shaped by the immunoproteasome versus the housekeeping protea some, respectively) 12 . This difference alone did not restore positive selection in these animals; by inference, peptides that are generated by β5t-containing thymoproteasomes are not only different but may also somehow bear unique biophysical features that are related to positive selection.
The putative significance of 'private' peptides. How could 'private' peptides on cTECs be specialized for positive selection? They might bind MHC molecules more weakly, as suggested by the observation that β5t-containing proteasomes, in contrast to those that contain β5 or β5i, inefficiently cleave substrates adjacent to hydrophobic amino acids 5, 13 . MHC class I molecules preferentially bind peptides with hydrophobic C termini. Therefore, 'wobbly' binding of β5t-derived peptides might result in a faster TCR off-rate and thereby promote positive selection -a scenario similar to the generation of partial agonists by altering the MHC anchor residues of immunogenic peptides 14 . Although attempts to compare the stability of pMHC Nature Reviews | Immunology Owing to a distinct proteolytic activity of the thymoproteasome, this is likely to lead to the generation of cTEC-specific 'private' peptide epitopes that differ from the 'public' epitopes that are generated through the housekeeping proteasome (β5) or the immunoproteasome (β5i). MHC class II-bound peptides on cTECs seem to be mostly derived from an unconventional, endogenous MHC class II-loading pathway that involves the macroautophagy-mediated shuttling of cytoplasmic proteins into lysosomes. In this proteolytic compartment, processing by the proteases cathepsin L and thymus-specific serine protease (TSSP) may generate unique 'private' peptides. MHC class II-bound peptides on mTECs may likewise be mostly derived from macroautophagy-mediated endogenous MHC class II loading; however, the lysosomal proteases that generate MHC class II-bound peptides in mTECs differ from those in cTECs, being essentially identical to those used by DCs for the processing of exogenously derived substrates along the 'conventional' exogenous MHC class II pathway. Of note, it is likely that the peptide-MHC (pMHC) ligandome of cTECs represents a mixture of 'private' and 'public' peptides that are uniquely present on cTECs or are shared with other antigen-presenting cells (APCs), respectively (see FIG. 4) . ER, endoplasmic reticulum; MIIC, MHC class II compartment; TAP, transporter associated with antigen processing.
CD5
A membrane protein that associates with the T cell receptor (TCR) complex. It modulates the TCR signal transduction cascade through interactions with various kinases and phosphatases.
NR4A1
NR4A1 encodes an orphan nuclear receptor that is upregulated by T cell receptor signalling in thymocytes and mature T cells.
HY TCR
An MHC class I-restricted transgenic T cell receptor (TCR) that recognizes a self antigen that is encoded by the Y chromosome.
OT-I TCR
An MHC class I-restricted transgenic T cell receptor (TCR) that recognizes a peptide epitope from ovalbumin.
Tonic TCR stimulation
Continuous 'subthreshold' recognition of self-peptide-MHC complexes by mature T cells, which results in a basal activation state that enables T cells to rapidly respond to foreign antigen.
complexes on cTECs with that on other APCs have so far failed to disclose such differences 11, 12 , there is independent evidence that β5t engenders a bias towards 'weak' interactions for positive selection. CD5 expression levels on single-positive (SP) thymocytes are thought to reflect the signalling intensity of the positively selecting TCR-pMHC interaction, and 'tuned' CD5 levels persist on mature peripheral T cells as a footprint of thymic selection 15 . Intriguingly, the diminished CD8 + SP thymocyte compartment that is found in β5t-deficient mice is mostly composed of cells that express elevated levels of CD5 as well as NR4A1(also known as NUR77), which suggests that positive selection in the absence of β5t mostly entails interactions that are of relatively higher affinity 12 . In the same vein, studies in TCR-transgenic mice showed that selection of 'natural' CD5 low clones -such as CD8 + T cells expressing the HY TCR -is highly dependent on β5t, whereas selection of CD5
hi clones -such as those expressing the OT-I TCR -is not. However, in studies using five different TCR-transgenic mice, the extent of the β5t dependency of developing thymocytes did not show a perfect inverse correlation with their CD5 expression levels 11 . Thus, thymoproteasome-derived peptides, and possibly private peptides that are generated through other cTEC-specific pathways, might favour the selection of CD5 low T cell clones.
Selection of TCRs across a range of affinities for self.
It has been suggested that the re-exposure of mature T cells to their positively selecting peptide (or peptides) is necessary for homeostasis through continual tonic TCR stimulation 16 . According to this scenario, T cells selected on 'private' pMHC ligands that are not re-encountered outside the thymus are predicted to have a competitive disadvantage during steady-state homeostasis. Consistent with this idea, mature CD5 low T cells in secondary lymphoid tissues are indeed less responsive to homeostatic cytokines when compared with their CD5 hi counterparts 17, 18 . In further support of such a link between thymic pMHC experience and mature T cell homeostasis, CD5 low T cells that express the β5t-dependent HY TCR are notoriously poor at homeostatic proliferation, whereas CD5 hi cells expressing the OT-I TCR, which is selected fairly efficiently in the absence of β5t, show robust homeostatic expansion 11 . Also, TCRs of CD5 low cells are 'preloaded' with less basal phosphorylation compared with TCRs of CD5 hi cells, which might put them at a competitive disadvantage in responding to foreign antigens 16, 19 . Indeed, in several models of infection in which polyclonal CD4 + T cell responses to pathogens have been examined, CD5 hi T cells outcompeted CD5 low T cells 19 . This observation led to the suggestion that the raison d'être of positive selection, rather than imprinting self-MHC restriction, is to bias T cell selection towards strongly self-reactive clones that are endowed with a homeostatic advantage and a head start in anti-pathogen responses 19 . Hence, the idea that private peptides skew positive selection towards CD5 low T cells that weakly respond to self may appear counter-intuitive.
CD5
low cells nonetheless do constitute a considerable fraction of the steady-state T cell repertoire 19 . So why would this be beneficial or even necessary for a functional immune system? First, a repertoire that is solely composed of clones with high self-reactivity might be prone to inciting autoimmunity. However, there is as yet no evidence to support this notion. For instance, β5t-deficient mice display intact negative selection 11 and do not exhibit any signs of autoimmunity. Second, the presumed competitive disadvantage of CD5 low clones that are selected through low-affinity interactions may in fact not be a general rule. Persaud et al. 20 compared two CD4 + T cell clones with identical affinities for a Listeria monocytogenes antigen; one was presumably selected and maintained by weak interactions with self, as inferred from its CD5 low phenotype, and the other was selected by stronger interactions -that is, being CD5 hi and displaying higher TCRζ phosphorylation. This alleged differential signalling strength during positive selection correlated with differences in basal TCR signalling in mature peripheral cells. Thus, the CD5 hi clone was poised to produce more IL-2 and this property, consistent with the 'tonic signalling' hypothesis, was actively maintained in the periphery through the recognition of unknown self-peptide-MHC ligands. Regardless of this difference, in the course of an L. monocytogenes infection, CD5 low and CD5 hi T cells showed comparable proliferative responses, and the CD5 hi clone eventually underwent more extensive cell death, so that in this case the CD5 low clone ultimately dominated the immune response.
Taken together, unusual antigen processing in cTECs seems to diversify the T cell repertoire for maximal versatility, as best exemplified by the thymoproteasome and CD8 + T cell selection. Interference with this cTEC-specific pathway of pMHC generation results in a 'crippled' CD8 + T cell repertoire that seems to be dominated by T cells with a higher affinity for self antigens. Corresponding consequences of cathepsin L deficiency or TSSP deficiency for the peripheral CD4 + T cell repertoire have yet to be described.
Negative selection in the cortex
As pointed out already, the vast majority of thymocyte death in the cortex can be attributed to the failure of a large proportion of DP cells to undergo positive selection 21 . Nonetheless, there is also a substantial loss of DP thymocytes through negative selection. Recent data show that the number of thymocytes that die through negative selection in the cortex is in fact much higher than previously appreciated and may even exceed the number of cells that pass through positive selection 22,23 . Using a TCR signalling reporter to identify thymocytes that were rescued from deletion in mice lacking BIM, it was estimated that 5 × 10 5 cells undergo negative selection in the cortex every day 23 . This figure not only exceeds the estimated number of positively selected cells but is also around twofold higher than the number of cells that are believed to undergo negative selection in the medulla. Intriguingly, cortical negative selection of thymocytes that are specific for 'ubiquitous' self antigens was shown to depend on a crucial contribution from dendritic cells (DCs). The heterogeneity and functional attributes of thymic DCs are discussed below in the section on medullary APCs. At this point, it may suffice to highlight that the crucial role of DCs in cortical negative selection is all the more remarkable considering that there are very few DCs in the cortex compared with the medulla and because 'ubiquitous' antigens are also predicted to be displayed by cTECs 24 . Possibly, these observations reflect an inherent inefficacy of cTECs to support negative selection. Consistent with this, imaging analyses of cortical negative selection in situ revealed that thymocytes arrest and signal adjacent to DCs, even when antigen is also displayed by cTECs 25 . Because these experiments involved the exogenous delivery of agonist peptide, cTEC-specific pathways of antigen processing are unlikely to be the sole determinant of this impaired capacity of cTECs to induce clonal deletion. Future experimentation is needed to assess the contribution of other candidate parameters such as co-stimulation, cell adhesion and MHC turnover.
Antigen presentation in the medulla
The medulla serves a crucial function for T cell tolerance induction. Indeed, the disruption of the threedimensional architecture of the medulla, disturbed development of its stromal components, impaired transit of positively selected thymocytes into the medulla or premature egress of thymocytes from the medulla all result in spontaneous manifestations of autoimmunity (reviewed in REFS 3, 26) . Central hallmarks of the thymic medulla that specify its crucial tolerogenic role include the 'ectopic' expression of a myriad of tissue-restricted antigens (TRAs) by medullary thymic epithelial cells (mTECs) and the presence of a unique ensemble of specialized haematopoietic APCs.
Medullary thymic epithelial cells
The phenomenon of promiscuous gene expression in mTECs has been reviewed in detail elsewhere 27, 28 . Some salient features of promiscuous gene expression and novel insights are highlighted in BOX 2. Although the entire mTEC population collectively expresses almost all 'peripheral' transcripts, each TRA is only expressed by a minor fraction (1-3%) of mTECs at any given time (FIG. 3) . How this mosaic expression pattern ultimately translates into the faithful presentation of thousands of self antigens in a way that ensures efficient tolerance remains puzzling.
Self antigens that are expressed by mTECs may be seen by T cells in two ways (FIG. 3) : first, through 'autonomous' presentation by mTECs themselves or, second, through antigen handover and presentation by neighbouring APCs. Direct presentation of endogenously expressed antigens by mTECs not only induces negative selection of CD8 + T cells 29, 30 but also efficiently elicits CD4 + T cell tolerance [31] [32] [33] [34] . At the same time, mTECs are conspicuously inefficient in the 'conventional' MHC class II-restricted presentation of extracellular substrates 35, 36 . Hence, mTECs have apparently evolved strategies to bypass the classical exogenous pathways of MHC class II loading in order to focus their MHC class II ligandome on endogenous self antigens.
Endogenous MHC class II loading in mTECs. How do mTECs load MHC class II molecules with intracellular antigens? Candidate pathways fall into two categories (reviewed in REF. 8 ). The first comprises mechanisms that are dependent on the proteasome and on the transporter associated with antigen processing (TAP), which implies a leakage of the content of the endoplasmic reticulum (ER) into MHC class II loading compartments. The second category comprises processes that are collectively known as autophagy ('self eating'): microautophagy, chaperone-mediated autophagy and macroautophagy. Their common principle is the delivery of cytoplasmic constituents to lysosomes, which presumably intersects with the MHC class II loading pathway 37 . So far, only the role of macroautophagy has been examined in the context of thymocyte selection. Athymic nude mice that were grafted with macroautophagy-deficient thymi displayed various manifestations of immune-mediated tissue damage, which is consistent with a crucial function of macroautophagy in TECs for loading peptides onto MHC class II molecules for T cell repertoire selection 9 . However, these studies did not address whether the observed symptoms actually reflected a failure of negative selection by mTECs or whether they were driven by impaired positive selection by autophagydeficient cTECs; these two possibilities are not mutually exclusive.
Box 2 | Promiscuous gene expression
The term 'promiscuous gene expression' refers to the ectopic expression of otherwise tissue-restricted antigens (TRAs) by medullary thymic epithelial cells (mTECs). Remarkably, besides tissue specificity, promiscuous gene expression violates other fundamental rules of tightly controlled lineage-specific gene expression, such as developmental switches and sex specificity, thus comprehensively representing the immunological self of peripheral tissues.
The autoimmune regulator (AIRE) protein remains the only identified molecular regulator that is dedicated to controlling a sizeable fraction of the promiscuously expressed gene pool 27 . It does not seem to act as a classical sequence-specific DNA-binding transcription factor. Instead, AIRE targets and turns on silent gene loci by binding to non-methylated histone 3 lysine 4 (H3K4), which marks promoters that are in closed chromatin regions 108, 109 . It apparently acts as a docking platform for different multi-protein complexes that are known to facilitate transcription by generating local double-strand breaks, promoting mRNA processing and relieving stalled RNA polymerase 110, 111 . Yet none of the presently discussed models of the function of AIRE 112 satisfactorily accounts for all of the intricacies of promiscuous gene expression, most notably the observation that a given TRA is only expressed by a minor subset (1-3%) of mTECs at any point in time ( see FIG. 3 ). Understanding how this mosaic pattern of promiscuous gene expression is generated and whether it is maintained in time and space at the single-cell level will be crucial for eventually comprehending how central tolerance can be so efficient, sensitive and stringent.
Although it was initially thought that promiscuous gene expression in single mTECs is stochastic 52, 54 , a recent study has revealed distinct and fluctuating patterns of gene co-expression in subsets of human mTECs, which implies that mTECs transiently display TRAs in certain linkage groups 53 . Co-expression groups ranged from approximately 100 to 300 TRAs, and preferentially mapped to particular chromosomes whereby co-expressed gene loci colocalized within nuclear subdomains, which suggests a level of regulation at the higher genome order.
More recent work has provided compelling evidence that macroautophagy does indeed support tolerogenic endogenous MHC class II loading in mTECs. When two closely related model antigens were targeted to the cytosol of mTECs, a variant that was earmarked for autophagosomal degradation was presented with much higher efficacy and displayed a superior capacity to induce the negative selection of CD4 + T cells compared with the antigen that was not marked for autophagy 38 . The same study also showed that a mitochondrial version of a model antigen required macroautophagy for tolerogenic presentation by TECs, whereas the direct presentation of a membrane-bound form of the same antigen was macroautophagy-independent 38 . Possibly, macroautophagy may be generally required for endogenous access to MHC class II substrates that reside in the Nature Reviews | Immunology . The mechanistic details of this 'directional antigen transfer' remain to be established. It is conceivable that TRAs are released or shed in a soluble form to be subsequently captured and processed by cDCs for presentation on MHC class I or class II. Apoptosis of terminally differentiated mTECs may lead to the release of apoptotic fragments that can also transfer mTEC-derived self antigens to cDCs. In addition, functional peptide-MHC ligands are unidirectionally translocated from mTECs to DCs 42, 119 .
Thymic crosstalk
The mutual developmental dependence of the T cell and the stromal cell (that is, non-T cell) compartments of the thymus, which is specified by complex receptor-ligand interactions.
C2TAkd mice
A mouse strain that expresses a designer microRNA that targets the MHC class 2 transactivator (C2TA) specifically in medullary thymic epithelial cells (mTECs). This leads to a reduction of MHC class II expression to approximately 10% of its physiological levels, while preserving intact mTEC differentiation and tissue-restricted antigen expression.
cytoplasm or within organelles -such as mitochondria, peroxisomes or the nucleus -which would be consistent with the role of autophagy in sampling these subcellular compartments 39 . By contrast, membrane proteins seem to be inherently able to access MHC class II loading compartments independently of macroautophagy 40 .
Direct versus indirect presentation of self antigens by mTECs.
A clear delineation of the quantitative or qualitative impact of direct versus indirect presentation of TRAs by mTECs or DCs (or any other thymic APC for that matter), respectively, is only slowly emerging, partly owing to potential redundancies between the two mechanisms. From the study of transgenic neoself antigens, there is a wealth of information supporting the idea that direct presentation by mTECs is an exquisitely efficient tolerance mechanism (reviewed in REF. 41 ). At the same time, there is accruing evidence that the medulla provides a specialized microenvironment that is conducive to intercellular antigen transfer 42 . However, few experimental models demonstrate an essential requirement for such antigen handover and some of these findings remain controversial 29, 43 . In a recent study, MHC class II tetramers were used to monitor the steady-state negative selection of polyclonal CD4 + T cells that were reactive to interphotoreceptor retinoid-binding protein (IRBP; also known as RBP3), which is an autoimmune regulator (AIRE)-dependent TRA that is exclusively expressed by mTECs. Ablating MHC class II expression in haematopoietic cells abolished the negative selection of T cells that are specific for this physiologically expressed self antigen, which indicates an essential requirement for inter cellular transfer between antigen-expressing mTECs and antigen-presenting haematopoietic APCs, at least for certain epitopes of IRBP 44 . A conclusive dissection of the dual role of mTECs (as antigen providers and presenters) in tolerizing the polyclonal T cell repertoire remains experimentally challenging. Selective ablation of either MHC class I or MHC class II expression in mTECs by conditional gene targeting has been surprisingly difficult to achieve. A further caveat of such an approach is that MHC class II-dependent thymic crosstalk between thymocytes and mTECs organizes mTEC differentiation 45 , such that the abolition of MHC class II expression on mTECs will most probably affect promiscuous gene expression in qualitative or quantitative terms. To avoid such confounding effects, an experimental strategy of tissue-specific knockdown of MHC class II molecules in transgenic mice (termed C2TAkd mice) has been devised 31 . The selective attenuation of antigen presentation by mTECs in these mice resulted in sporadic bouts of mild tissue infiltration, yet did not elicit overt autoimmunity. These findings contrast with the spontaneous autoimmunity that results from AIRE deficiency or even from selectively ablating the expression of single TRAs in mTECs 46, 47 . At first glance, this could be interpreted to indicate that direct antigen presentation to CD4 + T cells by mTECs, in contrast to TRA expression, is not essential to prevent autoimmunity; however, it is equally possible that the residual MHC class II expression on mTECs in C2TAkd mice might still suffice to censor autoreactive CD4 + T cells at the high-affinity end of the TCR spectrum.
In further support of a substantial autonomous contribution of mTECs as APCs for negative selection of polyclonal CD4 + T cells, the CD4 + SP thymocyte compartment in C2TAkd mice was markedly enlarged 31 . In fact, the decreased expression of MHC class II molecules on mTECs in these mice and the complete ablation of MHC class II expression on DCs in irradiated wild-type mice that were reconstituted with MHC class II-deficient bone marrow had a similar effect on the degree of negative selection within the CD4 + SP thymocyte compartment 31 . Moreover, combining haematopoietic MHC class II deficiency with reduced MHC class II expression on mTECs had an additive effect, which suggests a non-redundant contribution of both DCs and mTECs to negative selection.
Given the low frequency of mTECs that express and hence potentially present a given TRA 1 , 'saturating' tolerance induction through direct presentation would require exceedingly efficient scanning of numerous mTECs by thymocytes ( see FIG. 3 ). Real-time imaging of thymocyte motility showed that this is indeed the case: SP thymocytes 'randomly walk' within medullary areas at a velocity of 10 μm per minute, which allows them to engage in multiple contacts with APCs [48] [49] [50] . Estimates of the number of APCs that can be scanned within the 4-to 5-day sojourn of SP cells in the medulla vary from a few hundred to several thousand 1, 49, 51 . Bioinformatic modelling on the basis of TRA expression data at the single-cell level [52] [53] [54] predicts that 200-500 mTECs will be sufficient to cover the full TRA repertoire at a given point in time (B.K., H. Mayer and S. Pinto, unpublished observations). Shifting TRA expression patterns over time and corresponding fluctuations in the pMHC ligandome of individual mTECs would further reduce the minimal number of cells that need to be scanned, provided that T cells re-encounter the same mTEC over time 49, 53 . Notwithstanding a considerable error margin in these calculations, it seems that T cells may not even need to roam through large volumes of the medulla in order to saturate TRA encounters that result from autonomous presentation by mTECs.
Thymic dendritic cells
The overall contribution of DCs to total thymic cellularity is in the order of 0.5%. Thymic DCs can be subdivided into three major subsets 55 , two of which belong to the conventional -also known as classical -DC (cDC) lineage, whereas the remaining subset of thymic DCs belongs to the plasmacytoid DC (pDC) lineage. The heterogeneity of DCs in the thymus raises obvious questions with regard to the possible functional specialization of individual subtypes. Determinants of such a division of labour could include cell biological features of APC function (for example, antigen uptake and processing), intrathymic versus extrathymic origin and the positioning of DCs within distinct thymic micro environments. All of these features will eventually define the sampling territories of each subset and hence its self-peptide-MHC ligandome. 
SIRPα
− cDCs showed a superior cross-presentation capacity in vitro when compared to the migratory subset 58 . In vivo, intrathymic crosspresentation was found to contribute to CD8 + T cell tolerance towards a model antigen mimicking a TRA-like expression pattern in mTECs 29 . However, as these studies did not address the identity of the cross-presenting cell type, it remains to be established whether there is a differential contribution of resident versus migratory cDCs in this context.
Although DCs, on the whole, are markedly more abundant in the medulla than in the cortex, it is unclear whether this applies in equal terms to both migratory and resident cDCs. Recent work has identified XC-chemokine ligand 1 (XCL1; also known as lymphotactin) as a crucial determinant of the medullary localization of cDCs 59 , as XCL1-deficient mice have fewer medullary cDCs. Although not directly addressed in this study, the fact that only CD8α + cDCs express the receptor for XCL1 (XCR1) suggests that this mislocalization primarily affects resident, but not migratory, cDCs. As mTECs are the only thymic stromal cells that produce XCL1 (notably in an AIRE-dependent manner), the XCL1-XCR1 chemokine axis may coordinate the localization of resident cDCs next to mTECs. Such a close apposition should facilitate the transfer of mTECderived TRAs to DCs, although this has not yet been experimentally validated.
The migratory CD8α − SIRPα + cDC subset seems to be guided by different cues. Thus, CC-chemokine receptor 2 (CCR2)-deficient mice showed a selective diminution of migratory DCs in the thymus 60 , whereby CCR2 signalling seems to be crucial for the mobilization of peripheral SIRPα + cDCs rather than for their final intrathymic positioning. The same study showed that migratory cDCs can accumulate in the cortex in the vicinity of small vessels and inside perivascular regions, whereas other investigators have found that SIRPα + cDCs preferentially localized near blood vessels at the corticomedullary junction and within deeper regions of the medulla (D. Atibalentja and E. Unanue, personal communication). Notwithstanding these apparent discrepancies, there is some consensus that SIRPα + migratory cDCs sample intravenously injected model antigens from the bloodstream in vivo more efficiently than resident cDCs 35, [60] [61] [62] . Taken together, the differences between resident and migratory cDCs with respect to their origin, responsiveness to chemokines and selective occupancy of microenvironmental niches imply a degree of functional specialization. Resident cDCs preferentially seed the medulla and seem to be best equipped to focus their antigen display on self antigens that are captured within the thymic microenvironment. By contrast, migratory cDCs are found both in the medulla and the cortex and may serve a dual role: first, to transport peripherally acquired self antigens into the thymus, and second, to capture and present blood-borne self antigens. It is unlikely, however, that there is a strict demarcation between these functions.
Plasmacytoid dendritic cells.
Roughly one-third of all thymic DCs are pDCs. pDCs enter the thymus as a migratory population from peripheral sites 56 , which indicates a close lineage relationship between peripheral and thymic pDCs. As peripheral pDCs serve a crucial function in the protection against viral infections through their production of type I interferons 63 , the presence of a pDC population in the thymus was suggested to reflect a similar innate immune function in a primary lymphoid organ 55 . Given the poor antigen-presenting capacity of pDCs 64 , it had been considered rather unlikely that they would have a role in central tolerance; however, recent data suggest that this view may need to be revised. First, in a reductionist in vitro setting, thymic pDCs were capable of presenting peptide antigen to specific thymocytes and promoting their differentiation into T Reg cells 65 . Second, pDCs were reported to be surprisingly efficient in picking up soluble or particulate model antigens at peripheral sites and transporting them to the thymus in vivo 56, 66 . Interestingly, CCR9, which controls the homing of T cell progenitors to the thymus, is also crucial for pDC recruitment to the thymus 66 . A subset of CCR9 + immature pDCs in peripheral lymphoid tissues was able to promote the conversion of naive T cells into T Reg cells 67 and this 'tolerogenic' pDC subset may also exert tolerogenic functions upon recruitment into the thymus. Indeed, adoptively transferred, ovalbumin (OVA)-loaded wild-type pDCs, but not CCR9-deficient pDCs, migrated to the thymus where they specifically located to the medulla and promoted the clonal deletion of OVA-specific OT-II thymocytes 66 . Altogether, these new data present a strong case for a contribution of pDCs to central tolerance. Of note, in contrast to both subsets of cDCs, pDCs do not pick up mTEC-derived antigens (J. Nedjic, T. Yamano, J. Derbinski, L.K. and B.K., unpublished observations), which indicates that they may sample self antigens in the periphery and then 'freeze' their antigen cargo. Moreover, activation of Toll-like receptors (TLRs) prevents both cDCs and pDCs from migrating to the thymus 66, 68 , thereby conceivably preventing central tolerance to pathogens under inflammatory conditions. Finally, considering that CCR9 also promotes migration to the intestine, CCR9 + pDCs may sample not only bona fide self antigens but also innocuous foreign antigens, such as food components or constituents of the commensal microflora. However, as yet there are no experimental data to support this intriguing scenario.
Thymic B cells
Approximately 0.3% of thymic cells are B cells, which is a proportion similar to that seen for DCs. The origin of thymic B cells is still a matter of debate; it is unclear whether they derive from intrathymic B lymphopoiesis and/or immigration of peripheral B cells 69, 70 . The phenotypic and functional attributes of thymic B cells closely resemble those of conventional B cells (that is, B-2 cells) that are found in the periphery 71, 72 . However, compared with splenic B cells, thymic B cells show increased expression of MHC class II and co-stimulatory molecules, which is indicative of their potent antigenpresenting capacity. Indeed, many studies have shown that thymic B cells are capable of inducing negative selection. Most convincingly, myelin oligodendrocyte glycoprotein (MOG)-specific CD4 + thymocytes were negatively selected when an epitope of MOG was exclusively presented by B cells 73 . However, it is currently unclear how thymic B cells fare in their overall contribution to tolerance when compared with DCs and mTECs. For instance, deletion of superantigen-reactive CD4 + T cells was more efficiently induced by DCs, and in the same context B cells entirely failed to negatively select CD8 + thymocytes 74 . Consistent with these in vivo data, selective supplementation of reaggregate thymus organ cultures (RTOCs) with different thymic APCs in the presence of soluble OVA peptide resulted in the negative selection of OVA-specific CD4 + thymocytes when resident or migratory cDCs were used as APCs, but not when B cells were used 75 . Relatively little is known about the parameters that may shape the pMHC ligandome of thymic B cells. Traditionally, peripheral B cells are considered to be poor presenters of exogenous antigens. This may also be the case for thymic B cells, which would explain their poor performance in the aforementioned studies on negative selection in RTOCs. However, in contrast to the poor efficacy with which B cells present soluble antigens, B cell receptor (BCR)-mediated cognate interactions lead to exceptionally efficient antigen presentation 76 . Given the copious amounts of MHC class II molecules that are expressed by thymic B cells, it is conceivable that B cells may not only present BCR-captured external antigens but, in a manner similar to mTECs, they may focus their pMHC class II ligandome towards endogenously expressed proteins. This intracellular antigen pool is likely to include germline-encoded or even clonotype-specific regions of the BCR 77 . Lack of tolerance towards variable (V) regions of the BCR caused T cells to provide 'chronic' inappropriate help to B cells that expressed the respective BCR in a double-transgenic model 78 . This ultimately resulted in systemic autoimmunity 78 , which indicates that robust tolerance towards this special class of self antigens is indispensable.
Cognate interactions between B cells and T cells are crucial for germinal centre formation during immune responses to foreign antigens, but there may be an intriguing counterpart to these interactions in the central tolerance process. Thus, BCR-transgenic B cells efficiently mediated negative selection of CD4 + thymocytes expressing a transgenic TCR that was specific for the same cognate self antigen 72 . Although it may be difficult to envisage how rare cognate self antigen-specific B cells within a polyclonal repertoire may be sufficient to impose tolerance, the same study reported that even a polyclonal B cell population mediated a degree of deletion of TCR-transgenic CD4 + T cells. In summary, these intriguing new data should reignite interest in the role of B cells in central T cell tolerance. Thymic B cells may afford another layer of tolerance towards BCR-derived self-constituents, thus pre-empting previously described peripheral checkpoints of T cell tolerance to this unique class of self antigens 79 . Other relevant issues in this regard are whether the scope of B cell-mediated central T cell tolerance is indeed dictated by the BCR repertoire of thymic B cells, how diverse the thymic BCR repertoire is, and whether autoreactive B cells may be enriched in the thymus to allow for efficient presentation of soluble self antigens.
Perspectives
Following our discussion of the key cell biological attributes of the different thymic APC populations in the context of T cell repertoire selection, we close with some speculative thoughts on how the intrathymic encounter of self (or the lack thereof) may imprint peripheral T cell behaviour, coordinate dominant versus recessive mechanisms of tolerance and specify the targets of autoimmunity.
Positive selection, homeostatic fitness and immunity to pathogens. Our discussion of antigen presentation for positive selection converged on the view that cTECs generate and display functionally (and possibly structurally) distinct private self peptides that may sustain the selection of T cell clones that display weak tonic self-reactivity in the periphery. This notion is at odds with the proposition that the very same self peptides that mediate positive selection are also essential for naive T cell homeostasis in the periphery and act as co-agonists when T cells respond to foreign antigens 16, 80, 81 . How can this apparent discrepancy be reconciled? First, it is possible that the peripheral self peptides supporting homeostasis and co-activation are not identical, but instead are functionally equivalent to those that support positive selection. Second, one may argue that the functional competence of the peripheral T cell repertoire requires a balanced distribution of clones covering a relatively wide range of tonic self-reactivity, as represented by CD5 low and CD5 hi T cells. Possibly, a corresponding mix of private and public MHC ligands on cTECs is a prerequisite to select such a composite of T cell clones with low or high tonic affinity, respectively.
One can envisage a potential benefit of having T cells with a wide range of affinities for self antigens (FIG. 4) . Following infection with pathogens, T cells with high affinity for self could provide a rapid, yet relatively shortlived, initial immune response that is then followed by a sustained response by T cells with lower self affinity. The lower-affinity T cells are presumably not only less prone to burn out but also less likely to cause bystander damage to self tissues. This scenario would be consistent with the observation that β5t-deficient mice, which have a numerically smaller but presumably more strongly self-reactive CD8 + T cell repertoire, die in response to infection with influenza virus 11 . Yet, as the influenza virus-specific response was not tracked in this study, it remains to be determined whether these CD5
hi -skewed CD8 + T cells did indeed collapse faster, make an over-shooting pathogenic response or fail to respond to antigen at all. Against this background, it will also be interesting to see whether the duration of infections (chronic versus acute) or the spread of pathogens (systemic versus local) are crucial determinants of the relative contribution of CD5 low and CD5 hi T cell clones to the immune response to foreign antigens, and how these parameters affect their partitioning into the memory pool.
Notwithstanding these considerations, we still lack experimental data to directly link the selection of a given 'low self-affinity' TCR specificity to a specific private peptide, the processing of which would be dependent on any of the cTEC-specific pathways of antigen processing. Solving this issue has been hampered by our current ignorance of the identity of the peptides bound to MHC that are presented by cTECs. The scarcity of cTECs (1-3 × 10 4 per mouse thymus) renders this a low T cell clones via interactions at the lower end of the affinity range that is permissive for positive selection. One determinant of these 'low-strength' interactions could be that private peptides are weak MHC binders, which is indicated here by the loose fit between the peptide and MHC (double-headed arrows). Whether or not this is true, in the periphery, T cells that are selected on private peptides do not re-encounter the positively selecting peptides and hence do not receive tonic signals (middle and right panels). As a consequence, their CD3 ζ-chains are not preloaded with basal phosphorylation. Public peptides may preferentially support the selection of CD5 hi clones via positively selecting interactions at the relatively higher end of the affinity range (lower section of left panel). Public peptides might be good MHC binders that generate 'low-strength' interactions by loosely binding to the T cell receptor (TCR; indicated by the double-headed arrow). In the periphery, continual interactions with the very same peptides support T cell homeostasis and mediate partial CD3 ζ-chain phosphorylation (middle and right panels). During an immune response to foreign antigens, CD5 low and CD5 hi T cell clones of identical specificity may differentially respond with respect to the timing and magnitude of clonal expansion and contraction. The dominance of either type of responder might vary with parameters such as the duration and anatomical distribution of the infection. AICD, activation-induced cell death; DC, dendritic cell.
daunting task
. In this context, the fundamental issue of whether selection of a given TCR specificity actually requires a single specific self peptide has not been resolved. Likewise, we do not know whether private peptides on cTECs are equally important for CD4 + and CD8 + T cell repertoire selection. This question is all the more interesting as high tonic self-responders among naive CD4 + T cells seem inherently more prone to undergoing peripheral conversion into induced forkhead box P3 (FOXP3) + T Reg cells 82 .
Modes of central tolerance: deletion versus T Reg cell differentiation.
A detailed discussion of how antigen presentation in the thymus may operate alongside factors such as TCR affinity, access to cytokines or developmental tuning of thymocyte responsiveness to specify clonal deletion versus clonal deviation into the FOXP3 + T Reg cell lineage exceeds the scope of this article (for recent reviews, see REFS 83, 84) . Here, it may suffice to highlight two pertinent issues. First, there is no evidence to indicate that any thymic APC subset is specialized to exclusively promote clonal deletion or T Reg cell differentiation. Although efficient T Reg cell differentiation apparently requires a properly formed medullary microenvironment 85 , the overall size of the polyclonal T Reg cell pool is barely affected by the specific lack of DCs or subsets of mTECs, or by aberrant MHC class II expression on these cells (reviewed in REF. 86 ). Thus, thymic APC subsets can obviously compensate for each other as far as filling the physiological T Reg cell niche is concerned. However, considering the evidence for partly non-overlapping pMHC ligandomes on different thymic APCs, we deem it unlikely that this reflects a true redundancy at the level of TCR specificities that are recruited into the T Reg cell repertoire. Large-scale TCR sequencing of T Reg cell repertoires in the absence of DCs or mTEC subsets is expected to resolve this issue.
Second, it seems unlikely that any particular modality of antigen expression -for instance, a 'promiscuous gene expression-like' mosaic pattern versus ubiquitous expression -will invariably result in either clonal deletion or clonal deviation. The view that the essential role of AIRE in mTECs can be solely ascribed to recessive tolerance through negative selection 87 is difficult to reconcile with the ability of mTECs to autonomously induce antigen-specific T Reg cells in neo-self antigen transgenic settings 34 . A recent study extended the latter finding to a naturally expressed protein by showing that an AIREdependent self antigen induced thymic differentiation of cognate T Reg cells 88 . Intriguingly, T Reg cell progenitors of unknown specificity were found to compete for the recognition of rare stimulatory TCR self ligands in the thymus [89] [90] [91] , which is also suggestive of a link between promiscuous gene expression in rare mTECs and T Reg cell differentiation. The possibility that the expression and presentation of TRAs by very few mTECs may concomitantly induce negative selection and T Reg cell induction has obvious implications; interactions between thymocytes and rare APCs that present a given cognate self antigen perhaps need not be saturating after all, because the occasional escape of autoreactive T cells would be counterbalanced by dominant regulatory mechanisms.
Autoimmunity: what thymocytes may not see. With increasing knowledge of the multi-layered cellular and molecular mechanisms of central tolerance, one is bound to ask which parameters are most limiting and pose the highest risk for autoimmunity. Deep sequencing data of the mRNA signature of mTECs indicate that the scope of promiscuous gene expression is even broader than previously revealed by microarray analyses 92 . Given this apparently comprehensive intrathymic representation of otherwise tissue-specific transcriptomes, it becomes even more intriguing and informative to know which fraction Box 3 | Towards directly addressing the peptide-MHC ligandome of thymic stromal cells Remarkably, one of the first attempts in the early 1990s to assess the peptide-MHC (pMHC) ligandome by peptide elution and peptide sequencing reported a comparison between cortical thymic epithelial cells (cTECs) and splenic antigen-presenting cells (APCs) 113 . At the time, only 17 of the most abundant self peptides had been identified, from an estimated 2,000 to 10,000 distinct peptides presented by MHC class II or MHC class I molecules, respectively. With technology improving, the field has seen increasingly detailed assessments of cell type-specific pMHC ligandomes, particularly those of tumour cells. However, the ex vivo assessment of rare isolated populations, such as thymic stromal cells, remains a major technical challenge.
In general, naturally processed peptides have been characterized from acid extractions of affinity-purified MHC molecules, which are then sequenced, typically by mass spectrometry. This approach was used to describe peptides bound to MHC class I and II molecules in the human thymus 114, 115 . However, as whole tissue was used, these studies could not assign the identified peptides to particular stromal cell types. Another recent study identified 50-100 peptides from MHC class I or II molecules from human thymic dendritic cells (DCs) and compared these to peptides from thymic APCs depleted of DCs 116 , which gave an initial insight into differences in the ligandomes of thymic APCs. The amount of starting material required with this approach (at least 10 8 cells) so far precludes an informative analysis of MHC-bound peptides from rare populations like cTECs. Another complication arises from the possibility that the elusive 'private' self peptides, that are presumed to be generated by the thymoproteasome, may bind more weakly to MHC class I molecules and hence might be lost during the immunoprecipitation step. An alternative approach has been reported that characterizes peptides that are directly extracted with mild acid elution from the surface of intact cells. As this procedure generates a large number of peptides, not just those bound by MHC, the authors carried out a bioinformatic comparison to peptides that were extracted from MHC-deficient cells to assign them as 'MHC-bound' (REF. 117 ). Chemical and metabolic labelling have also been used to provide quantitative comparisons between two populations, although this has not been applied to the thymus 118 .
of self is actually not covered by central tolerance. Any advances in understanding the molecular regulation of promiscuous gene expression by AIRE and beyond would help us to understand how the tolerizing pMHC ligandome in the thymus is generated in the first place and, importantly, how dysregulation at the genetic, epigenetic and biochemical level could undermine central tolerance and thus possibly explain immune pathologies. In fact, an increasing number of examples show how 'holes' in central tolerance might specify dominant T cell targets in organ-specific autoimmune diseases.
First, very low expression levels of particular self antigens in human mTECs correlate with a high frequency of cognate autoreactive T cells and autoantibodies in the case of the myosin heavy chain 6 (REFS 93, 94) , which is an autoantigen in autoimmune myocarditis, or glutamate decarboxylase 2 (GAD2; also known as GAD65) (REF. 95 ) and zinc transporter 8 (ZNT8), which are both targets in type 1 diabetes (B.K., S. Pinto and R. Mallone, unpublished observations). Genetic polymorphisms in the regulatory regions of some autoantigens -which exert subtle effects on the expression level of self antigens in mTECs but not in peripheral tissues -correlate with susceptibility to organ-specific autoimmunity, as shown for insulin and type 1 diabetes [96] [97] [98] , the α-chain of the acetylcholine receptor and myasthenia gravis 99 , and for the thyroid-stimulating hormone receptor and Graves' disease 100 . Second, similar effects are observed when dominant T cell epitopes are only present in peripheral tissues but not in the thymus either owing to differential splicing 101, 102 or owing to 'mis-initiation' of mRNA transcription in mTECs 103 . Mis-initiated transcription is possibly a more general feature of promiscuous gene expression and may thus be a risk factor for autoimmunity 54 . Finally, post-translational modifications of autoantigens that affect T cell epitopes by cell-type specific expression of modifying enzymes in peripheral target tissues, but not mTECs, may have the same effect. Examples of this include glycosylation of collagen type II and citrullination of aggrecan and vimentin in the case of rheumatoid arthritis 104 , or deamidation of insulin in the case of type 1 diabetes 105 .
Conclusions
The affinity model remains a useful framework to conceptualize thymic selection events and there has been considerable progress in understanding how the TCR relays quantitative differences in signal strength into qualitatively different cell fates (reviewed in REF. 106 ). Yet, as reviewed here, a coherent model of thymocyte selection will also need to consider temporal, spatial and qualitative aspects of self recognition in distinct thymic microenvironments. In terms of positive selection, it remains tantalizing why 'monogamous' interactions between developing T cells and a single 'dedicated' stromal cell type are so important, and we have discussed how this crucial role of cTECs may be specified by their ability to generate 'private' pMHC ligands. With regard to central tolerance induction, it is intuitively obvious why 'promiscuity' -not only at the level of TRA expression in mTECs but also in terms of the diverse characteristics and sheer number of contributing APC subsets -is advantageous. Unravelling functional non-redundancies between tolerogenic APCs, at the level of the self antigen spectra that are presented and regarding tolerance mechanisms (clonal deletion versus T Reg cell induction), remains a major challenge for future investigations.
